Do R&D Spending And Approvals Really Measure Innovation?
CBO Report Suggests There’s A Bigger Story Than Numbers Tell
Executive Summary
A lot of new drugs aren’t really all that innovative, which complicates the view that lower profitability will mean less biopharma innovation.